Dr Moncef Slaoui, former pharma exec and chief Scientist for Trump’s “Operation Warp Speed,” which aims to develop a working Covid-19 vaccine as fast as possible, has more than $10 million in stock options in one of the companies receiving federal funding. Described across four separate filings, Slaoui has 155,438 options in Moderna. The stake…